Table 12. Summary of EORCT and PERCIST evaluation methods.
EORTC | PERCIST | |
---|---|---|
Measurable parameters/lesions | ||
Measurable lesion (threshold definition) | Viable tumor (SUV> surrounding background) | SULpeak >1.5 liver SULmean + 2DS |
Target lesions | Viable tumors; no number given (5 in study) | Highest SULpeak lesion (1 lesion) |
Measured parameter for metabolic response evaluation | ΔΣSUVmax target lesions | ΔΣSULpeak target lesion |
Response criteria | ||
CMR | No viable tumor | No lesion above > threshold |
PMR | Reduction of minimum of 25% in ΔΣSUVmax | Reduction of minimum of 30% in target measurable tumor 18F-FDG SUL peak |
SMD | Not CMR, PMD or PMR | Not CMR, PMD or PMR |
PMD | Increase in ΔΣSUVmax >25% or new lesion | Increase in SULpeak >30% or new lesion |
EORTC = European Organization for Research and Treatment of Cancer; PERCIST = PET Response Criteria in solid Tumours; CMR = Complete metabolic response; PMR = Partial metabolic response; SMD = Stable metabolic disease; PMD = Progressive metabolic disease